insulin drugs glp 1 receptor agonist market GLP-1 Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Size,
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (T2D)
For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity
-agonists-market-key-insight.png)
Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits
How many people take GLP-1 medications
